Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1β

Eur J Neurosci. 2022 Nov;56(10):5784-5794. doi: 10.1111/ejn.15828. Epub 2022 Oct 7.

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease that presents with fatigue, sleep disturbances, malaise, and cognitive problems. The pathogenesis of ME/CFS is presently unknown, and serum levels of potential biomarkers have been inconsistent. Here, we show that mitochondrial DNA (mtDNA) associated with serum exosomes, is increased in ME/CFS patients only after exercise. Moreover, exosomes isolated from patients with ME/CFS stimulate significant release of IL-1β from cultured human microglia. These results provide evidence that activation of microglia by serum-derived exosomes may serve as a potential novel pathogenetic factor and target for treatment of ME/CFS.

Keywords: allergies; cytokines; exosomes; extracellular vesicles; inflammation; mitochondrial DNA; myalgic encephalomyelitis/chronic fatigue syndrome; neuropeptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Mitochondrial / genetics
  • Exosomes*
  • Fatigue Syndrome, Chronic*
  • Humans
  • Microglia
  • Mitochondria

Substances

  • DNA, Mitochondrial